For years, regenerative medicine conversations often stayed confined within specialty silos.
Orthopedics focused on musculoskeletal healing.
Aesthetics focused on tissue quality and rejuvenation.
Pain medicine explored inflammation and recovery.
Hair restoration investigated regenerative support for graft survival and tissue health.
But increasingly, these conversations are beginning to overlap.
Physicians across specialties are now asking similar biologic questions:
How do tissues respond?
What influences regenerative signaling?
What creates greater consistency and predictability?
How do workflow and processing affect outcomes?
At ARTS 2026, these multidisciplinary conversations continue to expand.
Because regenerative medicine is no longer just about isolated procedures.
It is about understanding tissue biology more comprehensively.
We’re grateful for partners like EmCyte Corporation helping support physician education within this evolving landscape.